Bioxytran Statistics

Total Valuation

Bioxytran has a market cap or net worth of 3.85 million. The enterprise value is 4.63 million.

Market Cap	3.85M
Enterprise Value	4.63M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Bioxytran has 113.36 million shares outstanding. The number of shares has decreased by -33.73% in one year.

Current Share Class	113.36M
Shares Outstanding	113.36M
Shares Change (YoY)	-33.73%
Shares Change (QoQ)	+12.98%
Owned by Insiders (%)	0.63%
Owned by Institutions (%)	n/a
Float	112.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-1.48
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.18
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.16

Current Ratio	0.16
Quick Ratio	0.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-290.70%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	71.55%
Weighted Average Cost of Capital (WACC)	16.53%
Revenue Per Employee	n/a
Profits Per Employee	-1.06M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.89% in the last 52 weeks. The beta is 2.52, so Bioxytran's price volatility has been higher than the market average.

Beta (5Y)	2.52
52-Week Price Change	-79.89%
50-Day Moving Average	0.04
200-Day Moving Average	0.06
Relative Strength Index (RSI)	39.91
Average Volume (20 Days)	198,787

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.85M
Pretax Income	-2.12M
Net Income	-2.12M
EBITDA	-1.84M
EBIT	-1.85M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 509,914 in cash and 1.25 million in debt, giving a net cash position of -740,754 or -0.01 per share.

Cash & Cash Equivalents	509,914
Total Debt	1.25M
Net Cash	-740,754
Net Cash Per Share	-0.01
Equity (Book Value)	-2.59M
Book Value Per Share	-0.02
Working Capital	-2.74M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-526,455
Capital Expenditures	n/a
Depreciation & Amortization	11,544
Net Borrowing	323,090
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioxytran does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	33.73%
Shareholder Yield	33.73%
Earnings Yield	-55.21%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2